首鋼股份(000959.SZ)正籌劃發行股份購買京唐公司19.1823%股權 明起停牌
格隆匯 9 月 10日丨首鋼股份(000959.SZ)公佈,公司正在籌劃發行股份購買資產並募集配套資金事項。因該事項尚存不確定性,經公司向深圳證券交易所申請,公司股票自2020年9月11日開市起停牌。
此次交易標的資產為公司控股子公司首鋼京唐鋼鐵聯合有限責任公司(“京唐公司”)19.1823%股權。
京投控股、京國瑞擬分別向首鋼股份轉讓其持有的京唐公司11.5094%、7.6729%的股權,首鋼股份以發行股份的方式支付該等股權轉讓對價,且首鋼股份擬依據相關法律法規的規定同步向特定投資者非公開發行股票募集配套資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.